Influence of the in vivo half-antibody exchange on the therapeutic efficacy of an IgG4 antibody-drug conjugate

A high number of therapeutic antibodies and their derivates e.g. antibody-drug conjugates (ADC) are under preclinical or clinical evaluation for the treatment of cancer. Most of those ADCs are based on the IgG1 or IgG4 subtype, depending on whether additional effector functions are desired or not. I...

Full description

Saved in:
Bibliographic Details
Main Author: Herbener, Peter
Contributors: Maier, Uwe G. (Prof. Dr.) (Thesis advisor)
Format: Dissertation
Language:English
Published: Philipps-Universität Marburg 2018
Biologie
Subjects:
ADC
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!
No citations were found for this record.